4D pharma will participate in the Global Engage Microbiome Futures Conference in New York on May 23rd.
Company CEO, Duncan Peyton, will join other microbiome Key Opinion Leaders in a panel discussion on the future of microbiome research and commercialisation.
For further information, please see the Microbiome Futures website (http://www.global-engage.com/event/microbiome-futures/)
